Clinico-radiological Correlations in Cerebro-VASCULAR Disease

March 25, 2026 updated by: Anna del Poggio, IRCCS San Raffaele

Clinico-radiological Correlations in Cerebro-VASCULAR Disease: Toward a BetteR understAndINg of Their Heterogeneous Manifestations in a Retrospective and Prospective Observational Registry

This observational retrospective and prospective registry aims to explore the relationships between clinical manifestations and radiological findings in cerebrovascular diseases. These conditions are characterized by heterogeneous radiological presentations and different etiologies, posing challenges for accurate diagnosis and effective treatment. Understanding these correlations is essential for advancing diagnostic accuracy and therapeutic strategies.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

1143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The registry will focus on adults aged 18 to 100 of both genders diagnosed with various cerebrovascular diseases based on clinical and imaging evaluations. Participants will be selected from a retrospective registry of patients who have undergone MRI or CT scans for clinical indications. In addition to the retrospective cohort, the registry will also include a prospective component, enrolling newly diagnosed patients who meet the same eligibility criteria.

Description

Inclusion Criteria:

  • Age Range: 18-100 years old.
  • Must have undergone a CT or MRI scan of the central nervous system (CNS) (for clinical reasons).

Exclusion Criteria:

  • Alternative diagnosis to vascular pathology that explains clinical symptoms.
  • MRI or CT non-diagnostic or non-evaluable MRI due to motion artifacts.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients with each key MRI/CT finding in cerebrovascular disease (lesion location, vessel involvement, hemorrhagic transformation)
Time Frame: Baseline (at diagnosis), up to 20 years

Primary Outcome Measure:

Diagnostic imaging trends in cerebrovascular disease Description: Key imaging findings from first MRI/CT (e.g., lesion location, vessel involvement; %).

Baseline (at diagnosis), up to 20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

April 1, 2046

Study Completion (Estimated)

April 1, 2046

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 20, 2026

First Posted (Actual)

March 25, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • VASCULAR-BRAIN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebro Vascular Disease

Subscribe